Entering text into the input field will update the search result below

9 meters Biopharma announces deal for Phase 3 trial of celiac disease treatment

Words CELIAC DISEASE composed of wooden dices. Rye grains in the background.

TolikoffPhotography/iStock via Getty Images

  • 9 Meters Biopharma (NASDAQ:NMTR) said on Wednesday it had tied-up with Celiac.com, a website for gluten-free diet due to celiac disease, to help support clinical trial enrollment for its drug candidate larazotide to treat the gluten sensitivity disease.

Recommended For You

More Trending News

About NMTRQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NMTRQ--
9 Meters Biopharma, Inc.